Richmond Pharmaceutical Giant Phlow Raises $36 Million

Apr 6, 2023In the News

“Richmond pharmaceutical company Phlow Corp. has closed on a $36.1 million fundraising round targeted at growing its research and development capabilities.

The funding comes through several undisclosed sources, though Phlow CEO Eric Edwards said the round included returning investors and a “significant” healthcare system.

The bulk of the cash will go toward growing out the company’s contract development and manufacturing organization, which handles outsourced manufacturing for other pharma companies and research and development.”

Read More